Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,464.67
(
0.22%
)
News Focus
News Focus

Replies to post #78272 on Biotech Values

Replies to #78272 on Biotech Values
icon url

jbog

05/21/09 2:55 PM

#78274 RE: genisi #78272

All doses of once-daily QAB149 met their main target in Phase III trials for treating chronic obstructive pulmonary disease (COPD),

There's not much available in the way of treating COPD.
icon url

DewDiligence

05/21/09 5:19 PM

#78281 RE: genisi #78272

NVS has a number of drugs with big-selling potential in the late-stage pipeline. They will need all of them to contribute to make up for Diovan’s going off-patent.